Details for Patent: 7,364,752
✉ Email this page to a colleague
Summary for Patent: 7,364,752
Title: | Solid dispersion pharamaceutical formulations |
Abstract: | A pharmaceutical composition is disclosed which comprises a solid dispersion of an HIV protease inhibitor in a water soluble carrier, such as PEG, having enhanced bioavailability and improved dissolution properties. The solid dispersion may optionally be encapsulated in hard gelatin capsules, compressed into a tablet, or may be granulated with a pharmaceutically acceptable granulating agent. Also disclosed are methods of making said solid dispersion and methods of treating an HIV infection employing said solid dispersion. |
Inventor(s): | Fort; James J. (Midlothian, VA), Krill; Steven L. (Chatham, NJ), Law; Devalina (Libertyville, IL), Qiu; Yihong (Gurnee, IL), Porter; William R. (Vernon Hills, IL), Schmitt; Eric A. (Libertyville, IL) |
Assignee: | Abbott Laboratories (Abbott Park, IL) |
Application Number: | 09/709,829 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,364,752 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Delivery; Use; |
Drugs Protected by US Patent 7,364,752
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |